scholarly journals Negative correlation between bone mineral density and TSH receptor antibodies in long-term euthyroid postmenopausal women with treated Graves’ disease

2013 ◽  
Vol 6 (1) ◽  
pp. 11 ◽  
Author(s):  
Monica A Ercolano ◽  
Monica L Drnovsek ◽  
Maria C Silva Croome ◽  
Monica Moos ◽  
Ana M Fuentes ◽  
...  
Keyword(s):  
Bone Mineral Density ◽  
Postmenopausal Women ◽  
Bone Mineral ◽  
Negative Correlation ◽  
Tsh Receptor ◽  
Graves Disease ◽  
Mineral Density ◽  
Receptor Antibodies ◽  
Tsh Receptor Antibodies

scholarly journals Trajectories of Bone Remodeling Markers and Bone Mineral Density during Treatment with Strontium Ranelate in Postmenopausal Women Previously Treated with Bisphosphonates

2014 ◽  
Vol 7 ◽  
pp. CMED.S15086 ◽  
Author(s):  
Helisane Lima ◽  
Juliana Maia ◽  
Francisco Bandeira
Keyword(s):  
Bone Mineral Density ◽  
Lumbar Spine ◽  
Postmenopausal Women ◽  
Bone Mineral ◽  
Strontium Ranelate ◽  
Mineral Density ◽  
Bone Remodeling Markers ◽  
Before And After ◽  
Previously Treated

Objective To evaluate the responses of C-terminal telopeptide (CTX) and serum osteocalcin after the first 4 months of treatment with strontium ranelate (SR) and demonstrate their association with long-term bone density changes. Subjects and Methods A sample of 13 postmenopausal women with osteoporosis was analyzed (mean age 65 ± 7.7 years), who were treated with SR for an average of 2.56 ± 0.86 years. All patients had undergone previous treatment with bisphosphonates for an average period of 4.88 ± 2.27 years. Serum CTX and osteocalcin levels were determined before and after four months of treatment with SR. Bone mineral density in the lumbar spine and femoral neck were obtained before and after treatment with SR. Results We observed an average increase of 53.7% in the CTX levels, and 30.7% in the osteocalcin levels. The increase in bone markers was associated with a mean 4.8% increase in lumbar spine bone mineral density (BMD) from 0.820 to 0.860 g/cm2 ( T-score from –2.67 to –1.92; P= 0.001), after 2.5 years of treatment with SR. Conclusion These data suggest an anabolic effect of SR on postmenopausal women who were previously treated with long-term bisphosphonates.

Long-Term Effect of Exercise on Bone Mineral Density in Postmenopausal Women.

2004 ◽  
Vol 36 (Supplement) ◽  
pp. S106???S107
Author(s):  
Timothy Lohman ◽  
Ellen Cussler ◽  
Scott Going ◽  
Rob Blew ◽  
Linda Houtkooper ◽  
...  
Keyword(s):  
Bone Mineral Density ◽  
Postmenopausal Women ◽  
Bone Mineral ◽  
Term Effect ◽  
Mineral Density ◽  
Long Term Effect

Long-Term Effect of Exercise on Bone Mineral Density in Postmenopausal Women.

2004 ◽  
Vol 36 (Supplement) ◽  
pp. S106-S107
Author(s):  
Timothy Lohman ◽  
Ellen Cussler ◽  
Scott Going ◽  
Rob Blew ◽  
Linda Houtkooper ◽  
...  
Keyword(s):  
Bone Mineral Density ◽  
Postmenopausal Women ◽  
Bone Mineral ◽  
Term Effect ◽  
Mineral Density ◽  
Long Term Effect

Long-term adjuvant tamoxifen in early breast cancer: Effect on bone mineral density in postmenopausal women

Maturitas ◽  
1991 ◽  
Vol 13 (1) ◽  
pp. 87-88
Author(s):  
T. Fornander ◽  
L.E. Rutqvist ◽  
H.E. Sjoberg ◽  
L. Blomqvist ◽  
A. Mattsson ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Bone Mineral Density ◽  
Postmenopausal Women ◽  
Early Breast Cancer ◽  
Bone Mineral ◽  
Adjuvant Tamoxifen ◽  
Mineral Density

Month 3 and month 6 measurements of bone mineral density predict the annual outcome in postmenopausal women with osteoporosis in whom alendronate was added to long-term HRT

Maturitas ◽  
2003 ◽  
Vol 44 (4) ◽  
pp. 287-292 ◽  
Author(s):  
Amos Pines ◽  
Nachman Eckstein ◽  
Gideon Kopernik ◽  
Daniel Ayalon ◽  
Doron Comaneshter ◽  
...  
Keyword(s):  
Bone Mineral Density ◽  
Postmenopausal Women ◽  
Bone Mineral ◽  
Mineral Density
Sign in / Sign up

Export Citation Format

Share Document